Literature DB >> 600320

Peripheral and central muscarinic receptor affinity of psychotropic drugs.

B Fjalland, A V Christensen, J Hyttel.   

Abstract

The muscarinic receptor affinity of 27 psychotropic and 5 anticholinergic substances was examined in 2 in-vivo and 2 in-vitro models. A highly significant correlation was obtained between the effect of all compounds examined on the atropine sensitive binding of 3H-PrBCM and the effect in the conventional guinea-pig ileum preparation. Antagonism of oxotremorine induced tremors in mice by anticholinergics and neuroleptics was also significantly correlated to the corresponding data obtained in the in-vitro tests. Due to very low potency in the physostigmine induced mortality test in mice too few ED50 values were obtained to perform statistical comparisons. It is concluded, that the conventional guinea-pig ileum model and the 3h-prBCM binding model are equally predictive as tests for antimuscarinic properties. When in-vivo anticholinergic data for neuroleptics are used it must be considered that a possible dopamine receptor blockade may diminish the antimuscarinic effect of the substance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 600320     DOI: 10.1007/bf00501257

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Are muscarinic receptors in the central and peripheral nervous system different?

Authors:  A J Beld; S Van Den Hoven; A C Wouterse; M A Zegers
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

2.  The peripheral actions of oxotremorine, a metabolite of tremorine.

Authors:  A K CHO; W L HASLETT; D J JENDEN
Journal:  J Pharmacol Exp Ther       Date:  1962-11       Impact factor: 4.030

3.  Binding of agonists and antagonists to muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; C R Hiley; E C Hulme
Journal:  J Supramol Struct       Date:  1976

4.  Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

5.  The properties of muscarinic receptors in mammalian cerebral cortex.

Authors:  A S Burgen; C R Hiley; J M Young
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

6.  Methylphenidate antagonism of haloperidol, interaction with cholinergic and anticholinergic drugs.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

7.  A simple screening method for antiparkinsonian drugs in mice.

Authors:  T Nose; M Kojima
Journal:  Eur J Pharmacol       Date:  1970-04       Impact factor: 4.432

8.  [Neuroleptics. A review].

Authors:  O H Robak
Journal:  Tidsskr Nor Laegeforen       Date:  1977-02-20

9.  The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance.

Authors:  T D Inch; D M Green; P B Thompson
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

10.  A comparison of the affinities of antagonists for acetylcholine receptors in the ileum, bronchial muscle and iris of the guinea-pig.

Authors:  R B Barlow; F M Franks; J D Pearson
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

View more
  9 in total

1.  Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

Authors:  P Hartvig; S A Eckernäs; L Lindström; B Ekblom; U Bondesson; H Lundqvist; C Halldin; K Någren; B Långström
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors.

Authors:  P R Golds; F R Przyslo; P G Strange
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

3.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.

Authors:  Y Chaput; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

4.  Effect of imipramine in the "learned helplessness" model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine.

Authors:  M Geoffroy; J Scheel-Krüger; A V Christensen
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.

Authors:  R Rivest; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

6.  Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain.

Authors:  E El-Fakahany; E Richelson
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

7.  Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs.

Authors:  J D Leander
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Comparison of the effects of binodaline and amitriptyline on peripheral autonomic functions in healthy volunteers.

Authors:  J Longmore; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

9.  The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart.

Authors:  H Fuder; C Meiser; H Wormstall; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.